News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,058 Results
Type
Article (14277)
Company Profile (282)
Press Release (254499)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79546)
Career Advice (153)
Deals (13232)
Drug Delivery (35)
Drug Development (50469)
Employer Resources (31)
FDA (5728)
Job Trends (5139)
News (144463)
Policy (10034)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21682)
ALS (69)
Alzheimer's disease (851)
Antibody-drug conjugate (ADC) (109)
Approvals (5755)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (233)
Bladder cancer (60)
Brain cancer (20)
Breast cancer (162)
Cancer (1531)
Cardiovascular disease (121)
Career advice (134)
Career pathing (2)
CAR-T (126)
Cell therapy (346)
Cervical cancer (9)
Clinical research (41187)
Collaboration (562)
Compensation (283)
Complete response letters (13)
COVID-19 (1034)
CRISPR (44)
C-suite (173)
Cystic fibrosis (78)
Data (1630)
Denatured (11)
Depression (32)
Diabetes (142)
Diagnostics (1304)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (86)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (93)
Earnings (30191)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48828)
Executive appointments (477)
FDA (6506)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (520)
Gene editing (102)
Generative AI (10)
Gene therapy (270)
GLP-1 (373)
Government (1084)
Grass and pollen (2)
Guidances (73)
Healthcare (6595)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1101)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7282)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (215)
Leadership (3)
Legal (1386)
Liver cancer (34)
Lung cancer (208)
Lymphoma (105)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (64)
Medical device (2604)
Medtech (2605)
Mergers & acquisitions (6294)
Metabolic disorders (408)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (74)
Neuropsychiatric disorders (25)
Neuroscience (1280)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (124)
Partnered (8)
Patents (137)
Patient recruitment (83)
Peanut (35)
People (25691)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14553)
Phase II (19167)
Phase III (12099)
Pipeline (983)
Policy (49)
Postmarket research (852)
Preclinical (6164)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (299)
Real estate (1419)
Recruiting (12)
Regulatory (8680)
Reports (17)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (101)
Series B (70)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1977)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (217)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (135)
Last 7 days (605)
Last 30 days (1988)
Last 365 days (19379)
2025 (7227)
2024 (20552)
2023 (22415)
2022 (26824)
2021 (27805)
2020 (23359)
2019 (16223)
2018 (11739)
2017 (13745)
2016 (11840)
2015 (14350)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17356)
Australia (2946)
California (4115)
Canada (1184)
China (378)
Colorado (154)
Connecticut (156)
Delaware (110)
Europe (37364)
Florida (501)
Georgia (125)
Idaho (16)
Illinois (242)
India (10)
Indiana (94)
Iowa (2)
Japan (80)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (499)
Massachusetts (3279)
Michigan (74)
Minnesota (153)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1016)
New Mexico (12)
New York (1099)
North Carolina (572)
North Dakota (5)
Northern California (1846)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (775)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (5)
Southern California (1575)
Tennessee (25)
Texas (478)
United States (14031)
Utah (56)
Virginia (85)
Washington D.C. (31)
Washington State (363)
Wisconsin (18)
269,058 Results for "quince therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Quince Therapeutics to Present at Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
May 13, 2025
·
7 min read
Press Releases
Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
April 4, 2025
·
1 min read
Press Releases
Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
March 24, 2025
·
9 min read
Press Releases
Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 5, 2025
·
1 min read
Biotech Bay
Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Quince Therapeutics, Inc. (Nasdaq: QNCX) today announced that Dirk Thye, M.D., Quince’s Chief Executive Officer and Chief Medical Officer, will present at The Citizens JMP Life Sciences Conference on Monday, May 13, 2024 beginning at 1:30 p.m. Eastern Time.
May 6, 2024
·
1 min read
Press Releases
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
February 7, 2025
·
7 min read
Press Releases
Quince Therapeutics Appoints Renowned Pediatric Neurologist Dr. William Whitehouse to Scientific Advisory Board
January 23, 2025
·
5 min read
Press Releases
Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
January 27, 2025
·
8 min read
Press Releases
Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia
January 28, 2025
·
2 min read
1 of 26,906
Next
